Verition Fund Management’s QuidelOrtho QDEL Stock Holding History

Verition Fund Management’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,000	Closed	-$337K	–	2926
2022 Q1	$337K	Buy	+3,000	New	+$320K	﹤0.01%	2100

Other funds holding QDEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Verition Fund Management's QDEL Position: Q2 2026 in Review

Verition Fund Management sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 13,084 shares — an estimated $215K sold.

Verition Fund Management first reported a position in QDEL in Q2 2018 and held it in 15 quarters. The position peaked at $3.46M in Q1 2025. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

Verition Fund Management reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
Verition Fund Management sold 13,084 QuidelOrtho shares in Q2 2026, an estimated $215K.
Verition Fund Management first reported a position in QuidelOrtho in Q2 2018 and held it in 15 quarters.
Verition Fund Management's QuidelOrtho position peaked at $3.46M in Q1 2025.
245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.